Searched for
VACCINE MATERIAL BAN
How Congo is battling an Ebola outbreak complicated by aid cuts, armed rebels and angerEbola treatment centers in eastern Congo are being attacked. This violence stems from deep-seated issues like rebel conflict and displaceme...- Attacks on Ebola treatment centers are one of several problems affecting Congo's outbreak responseIn the Eastern Congo, a troubling surge of Ebola is compounded by deliberate attacks on medical facilities, igniting frustration among the ...
- Pak initiates 'emergency' steps to secure drug supplies after trade suspension with IndiaFollowing trade suspension with India, Pakistani health authorities are taking "emergency preparedness" steps to secure pharmaceutical supp...
- International travel should be made easier through mutual recognition of vaccine certificates: PM ModiIn his video remarks at the Global COVID Summit hosted by US President Joe Biden, Modi also said India is ramping up production capacity of...
- US confirms lifting of ban on vaccine raw material suppliesThe US on Wednesday informed India it has lifted all restrictions on exports of materials and components for production of Covid-19 vaccine...
- Relief for Serum Institute of India as US lifts curbs on vaccine inputs“This policy change will hopefully increase the supply of raw material globally and to India, boosting our vaccine production capacity and ...
- Serum’s launch of Novavax shot in India may face delayAdar Poonawalla had complained in the past that the manufacturing of the Novavax vaccine was getting delayed due to a shortage of raw mater...
- US should grant India special waiver from DPA for vaccine raw materialsThe United States ought to consider granting India a special exemption or waiver from the imposition of its Defence Production Act (DPA) on...
- US defends restrictions on export of COVID-19 vaccine raw materials amid India's request to lift ban"That campaign is well underway, and we're doing that for a couple of reasons. Number one, we have a special responsibility to the American...
- 'We understand India's pharmaceutical requirements': Biden admin on Covid-19 vaccine's raw material supply issuesIn reality the prioritization translates into a ban and requires a political decision, observers said. The White House has to take a call b...
- India hopes U.S. will soon ease ban on vaccine material exports - sourcesIndian Foreign Minister Subrahmanyam Jaishankar tweeted that he and U.S. Secretary of State Antony Blinken had discussed, among other thing...
- COVID-19: WH refuses to comment on lifting ban on vaccine raw materials export to IndiaBoth Dr Anthony Fauci, Director at the National Institute of Allergy and Infectious Diseases and Dr Andy Slacitt, the White House COVID-19 ...
- US ban on export of vaccine material hampering production in India: CPI(M)Accusing the US of "doublespeak", the Left party pointed out that at the Quad summit held on March 12, a joint statement issued by the memb...
- Serum Institute's Adar Poonawalla urges US to lift raw material export ban to ramp up vaccine productionSII is currently manufacturing anti-coronavirus vaccine Covishield, developed by AstraZeneca and Oxford University. The vaccine is not only...
- India's vaccinations fall from peak, raw-material shortage hits output targetsAfter giving and selling tens of millions of COVID-19 vaccine doses abroad, India has suddenly found itself short of shots. It has abruptly...
- Supply of vaccines abroad would continue keeping in mind domestic requirements: MEAOn the issue of procurement of raw materials from the US for vaccines manufacturing, the MEA spokesperson recalled that Foreign Secretary H...
- Vaccine nationalism is threatening WHO’s 2021 goal of 2 billion doses, says Adar PoonawallaMany manufacturers, including Serum, already have missed timelines and commitments, Poonawalla said in an interview. It will take two to th...
- India takes up with US ban on exports of Covid-19 vaccine raw materialsLast week, Serum Institute of India (SII) CEO Adar Poonawalla had rued that the production of Covid-19 vaccines and global availability cou...
- Adar Poonawalla, WHO warn of delays as US prioritises PfizerAdar Poonawalla, the chief executive officer of the Serum Institute of India —which is licensed to produce hundreds of millions of Covid-19...
- US export curbs can limit COVID-19 vaccine production, availability: SII CEO Adar PoonawallaSII, the world's biggest vaccine maker, has licensed the AstraZeneca/Oxford University product and will soon start bulk-manufacturing the N...
Load More
